97 related articles for article (PubMed ID: 11249967)
1. The novel analgesic, cizolirtine, inhibits the spinal release of substance P and CGRP in rats.
Ballet S; Aubel B; Mauborgne A; Poliénor H; Farré A; Cesselin F; Hamon M; Bourgoin AS
Neuropharmacology; 2001 Mar; 40(4):578-89. PubMed ID: 11249967
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of the novel analgesic, S 12813-4, on the spinal release of substance P- and calcitonin gene-related peptide-like materials in the rat.
Collin E; Frechilla D; Pohl M; Bourgoin S; Mauborgne A; Hamon M; Cesselin F
Naunyn Schmiedebergs Arch Pharmacol; 1994 Apr; 349(4):387-93. PubMed ID: 7520130
[TBL] [Abstract][Full Text] [Related]
3. Monoaminergic control of the release of calcitonin gene-related peptide- and substance P-like materials from rat spinal cord slices.
Bourgoin S; Pohl M; Mauborgne A; Benoliel JJ; Collin E; Hamon M; Cesselin F
Neuropharmacology; 1993 Jul; 32(7):633-40. PubMed ID: 7689707
[TBL] [Abstract][Full Text] [Related]
4. Antihyperalgesic effects of cizolirtine in diabetic rats: behavioral and biochemical studies.
Aubel B; Kayser V; Mauborgne A; Farré A; Hamon M; Bourgoin S
Pain; 2004 Jul; 110(1-2):22-32. PubMed ID: 15275748
[TBL] [Abstract][Full Text] [Related]
5. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo.
Collin E; Frechilla D; Pohl M; Bourgoin S; Le Bars D; Hamon M; Cesselin F
Brain Res; 1993 Apr; 609(1-2):211-22. PubMed ID: 8389648
[TBL] [Abstract][Full Text] [Related]
6. gamma-Aminobutyric acid, through GABAA receptors, inhibits the potassium-stimulated release of calcitonin gene-related peptide- but not that of substance P-like material from rat spinal cord slices.
Bourgoin S; Pohl M; Benoliel JJ; Mauborgne A; Collin E; Hamon M; Cesselin F
Brain Res; 1992 Jun; 583(1-2):344-8. PubMed ID: 1380400
[TBL] [Abstract][Full Text] [Related]
7. Increased in vivo release of calcitonin gene-related peptide-like material from the spinal cord in arthritic rats.
Collin E; Mantelet S; Frechilla D; Pohl M; Bourgoin S; Hamon M; Cesselin F
Pain; 1993 Aug; 54(2):203-211. PubMed ID: 8233535
[TBL] [Abstract][Full Text] [Related]
8. Release of calcitonin gene-related peptide (CGRP), substance P (SP), and vasoactive intestinal polypeptide (VIP) from rat spinal cord: modulation by alpha 2 agonists.
Takano M; Takano Y; Yaksh TL
Peptides; 1993; 14(2):371-8. PubMed ID: 7683402
[TBL] [Abstract][Full Text] [Related]
9. Effects of the novel analgesic, cizolirtine, in a rat model of neuropathic pain.
Kayser V; Farré A; Hamon M; Bourgoin S
Pain; 2003 Jul; 104(1-2):169-77. PubMed ID: 12855326
[TBL] [Abstract][Full Text] [Related]
10. Polyarthritis-associated changes in the opioid control of spinal CGRP release in the rat.
Ballet S; Mauborgne A; Benoliel JJ; Bourgoin S; Hamon M; Cesselin F; Collin E
Brain Res; 1998 Jun; 796(1-2):198-208. PubMed ID: 9689470
[TBL] [Abstract][Full Text] [Related]
11. Adenosine receptor-mediated control of in vitro release of pain-related neuropeptides from the rat spinal cord.
Mauborgne A; Poliénor H; Hamon M; Cesselin F; Bourgoin S
Eur J Pharmacol; 2002 Apr; 441(1-2):47-55. PubMed ID: 12007919
[TBL] [Abstract][Full Text] [Related]
12. Twenty six-week repeat dose oral rat toxicity study of cizolirtine, a substance-P and calcitonin gene-related peptide release modulator.
Guzmán A; Encina G; Fernández de Henestrosa AR; Vila C; Tortajada A; Marín AP
Regul Toxicol Pharmacol; 2021 Jun; 122():104916. PubMed ID: 33711392
[TBL] [Abstract][Full Text] [Related]
13. Nerve growth factor treatment increases stimulus-evoked release of sensory neuropeptides in the rat spinal cord.
Malcangio M; Garrett NE; Tomlinson DR
Eur J Neurosci; 1997 May; 9(5):1101-4. PubMed ID: 9182964
[TBL] [Abstract][Full Text] [Related]
14. A-995662 [(R)-8-(4-methyl-5-(4-(trifluoromethyl)phenyl)oxazol-2-ylamino)-1,2,3,4-tetrahydronaphthalen-2-ol], a novel, selective TRPV1 receptor antagonist, reduces spinal release of glutamate and CGRP in a rat knee joint pain model.
Puttfarcken PS; Han P; Joshi SK; Neelands TR; Gauvin DM; Baker SJ; Lewis GR; Bianchi BR; Mikusa JP; Koenig JR; Perner RJ; Kort ME; Honore P; Faltynek CR; Kym PR; Reilly RM
Pain; 2010 Aug; 150(2):319-326. PubMed ID: 20621685
[TBL] [Abstract][Full Text] [Related]
15. Effect of the tachykinin NK1 receptor antagonists, RP 67580 and SR 140333, on electrically-evoked substance P release from rat spinal cord.
Malcangio M; Bowery NG
Br J Pharmacol; 1994 Oct; 113(2):635-41. PubMed ID: 7530576
[TBL] [Abstract][Full Text] [Related]
16. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C.
Fehrenbacher JC; Taylor CP; Vasko MR
Pain; 2003 Sep; 105(1-2):133-41. PubMed ID: 14499429
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of cizolirtine: a new analgesic agent.
Alvarez I; Andreu F; Buxens J; Colombo M; Dordal A; Fort M; Gutiérrez B; Farré AJ
Methods Find Exp Clin Pharmacol; 2000 May; 22(4):211-21. PubMed ID: 10939032
[TBL] [Abstract][Full Text] [Related]
18. Sumatriptan inhibits the release of CGRP and substance P from the rat spinal cord.
Arvieu L; Mauborgne A; Bourgoin S; Oliver C; Feltz P; Hamon M; Cesselin F
Neuroreport; 1996 Aug; 7(12):1973-6. PubMed ID: 8905706
[TBL] [Abstract][Full Text] [Related]
19. The role of spinal neuropeptides and prostaglandins in opioid physical dependence.
Trang T; Sutak M; Quirion R; Jhamandas K
Br J Pharmacol; 2002 May; 136(1):37-48. PubMed ID: 11976266
[TBL] [Abstract][Full Text] [Related]
20. Intraplantar injection of a cyclooxygenase inhibitor ketorolac reduces immunoreactivities of substance P, calcitonin gene-related peptide, and dynorphin in the dorsal horn of rats with nerve injury or inflammation.
Ma W; Eisenach JC
Neuroscience; 2003; 121(3):681-90. PubMed ID: 14568028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
